Check Cap Ltd logo
CHEKCheck Cap Ltd
Trade CHEK now
Company banner image

About Check Cap Ltd

Check Cap (NASDAQ:CHEK) is focused on redefining the screening process for colorectal cancer with its innovative C-Scan system, which uses advanced imaging technology to detect polyps and other abnormalities in the colon. The company operates primarily in the medical diagnostics sector, emphasizing the development and commercialization of its non-invasive, patient-friendly solutions. Key projects center around clinical trials and regulatory approvals aimed at bringing the C-Scan system to broader markets. Check Cap's objectives include advancing its technology to increase early detection rates and improving patient compliance with screening protocols. By prioritizing innovation and accessibility, Check Cap aims to contribute significantly to the early detection and prevention of colorectal cancer.

What is CHEK known for?

Snapshot

Public US
Ownership
-
Year founded
0
Employees
Isfiya, Israel
Head office
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
State of Israel

Produtos e/ou serviços de Check Cap Ltd

  • The C-Scan System is a non-invasive capsule-based screening tool designed to detect polyps and abnormalities in the colon without the need for bowel preparation or invasive procedures.
  • Development efforts focus on enhancing the C-Scan technology, improving its diagnostic accuracy, patient comfort, and integration with healthcare systems for widespread adoption in colorectal cancer screening.
  • Clinical trials and research aim to validate the effectiveness of the C-Scan System, gathering data to meet regulatory requirements and secure approvals for commercial use in various regions.
  • Strategic partnerships and collaborations are established to expand the global reach of the C-Scan technology, fostering relationships with healthcare providers, distributors, and research institutions.
  • Investment in intellectual property and patents ensures the protection of the C-Scan technology, securing competitive advantage in the colorectal cancer screening market.
  • Educational programs and resources are created to raise awareness among healthcare professionals and patients about the benefits and application of capsule-based colorectal cancer screening systems.

equipe executiva do Check Cap Ltd

  • Mr. David LontiniInterim CEO & Chairman of the Board
  • Ms. Noa Reshef M.B.A.Head of Operations

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.